BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2017
View Archived Issues
Health Canada approves Roche's cobas EGFR Mutation Test v2
Read More
twoXAR reports promising results for liver cancer candidate TXR-311 in cell-based assays
Read More
INCJ, Takeda and Medipal announce plans for new company Scohia Pharma
Read More
PeptiMimesis receives second tranche of investment
Read More
Aeolus reports potential of AEOL-20415 for cystic fibrosis
Read More
Preclinical and first patient evaluation of (99m)Tc-PSMA-I&S in prostate cancer
Read More
Catalyst Pharmaceuticals reports data on Firdapse in MuSK antibody-positive myasthenia gravis
Read More
First-in-human data for venetoclax in patients with relapsed or refractory non-Hodgkin's lymphoma
Read More
Mateon reports third cohort data from phase Ib study of OXi-4503 in AML and MDS
Read More
Schizophrenia research at Feinstein Institute for Medical Research supported by NIH grant
Read More
MAGEL2 gene nonsense mutation found in a patient with Opitz-C syndrome
Read More
Therapix and Rafa sign a memorandum of understanding for venture formation
Read More
Wakamoto completes Japanese phase I trial of WP-1303
Read More
Peptonic Medical refocuses development of Vagitocin based on initial phase IIb results
Read More
Servier to cease European marketing of Protelos/Osseor
Read More
European Commission approves Cinryze to prevent and treat HAE attacks in children
Read More
GSK seeks U.S. approval for use of Fluarix Quadrivalent in infants age 6 months and older
Read More
Oxidized CaMKII inhibition could alleviate asthma
Read More
Glycyx and Valeant agree to licensing deal for methylnaltrexone bromide in oncology
Read More
Trovagene and Nerviano sign licensing agreement for NMS-1286937
Read More
Medivir out-licenses commercial rights in order to focus fully on R&D
Read More
CD47 determined as a poor prognostic factor for multiple myeloma patients
Read More
Clarivate Analytics launches Drug Research Advisor with target identification app
Read More
